Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

Eugenia Girda, Lorna Rodrı́guez-Rodrı́guez|International Journal of Gynecological Cancer|2022

Cited by 14